VitaNova Life Sciences (VNOV) Net Cash Flow (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Net Cash Flow came in at $6965.0 in Q3 2026, down 97.36% YoY from $263811.0 in Q3 2025, and down 98.37% on a QoQ basis from $428313.0 in Q2 2026.
Analysis
VitaNova Life Sciences (VNOV) Net Cash Flow (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed Net Cash Flow across 8 years of filings, most recently posting $6965.0 for Q3 2026.
- Net Cash Flow for Q3 2026 came in at $6965.0, down 97.36% year-over-year; the trailing twelve-month figure through Jul 2026 was $557561.0 (down 38.39% YoY), and the FY2026 annual result was $814407.0, up 329.15% from the prior year.
- Net Cash Flow for Q3 2026 stood at $6965.0, down from $428313.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $808356.0 in Q1 2024 and bottomed at -$451401.0 in Q3 2024.
- Average Net Cash Flow over 5 years is $87360.5, with a median of $6043.5 recorded in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 3443.49% in 2024 and fell as far as 9323.19% in 2024.
- Year by year, Net Cash Flow stood at $5306.0 in 2022, then tumbled by 264.49% to -$8728.0 in 2023, then jumped by 1029.88% to $81160.0 in 2024, then jumped by 162.03% to $212660.0 in 2025, then tumbled by 96.72% to $6965.0 in 2026.
- The last three Net Cash Flow figures came in at $6965.0 (Q3 2026), $428313.0 (Q2 2026), and -$90377.0 (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 813.51 Mn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 177.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | -167.62 Mn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | -188.00 Mn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 7.75 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | -37.29 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 74.92 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | -35.06 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | -290.67 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | 6,965.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 428,313.00 |
| Jan 31, 2026 | -90,377.00 |
| Oct 31, 2025 | 212,661.00 |
| Jul 31, 2025 | 263,810.00 |
| Apr 30, 2025 | 377,637.00 |
| Jan 31, 2025 | 182,378.00 |
| Oct 31, 2024 | 81,160.00 |
| Jul 31, 2024 | -451,401.00 |
| Apr 30, 2024 | -215,320.00 |
| Jan 31, 2024 | 808,356.00 |
| Jul 31, 2023 | -8,728.00 |
| Apr 30, 2023 | -2,285.00 |
| Jan 31, 2023 | -24,177.00 |
| Oct 31, 2022 | 5,306.00 |
| Jul 31, 2022 | 6,781.00 |
| Apr 30, 2022 | -13,832.00 |
| Jan 31, 2022 | 5,242.00 |
| Oct 31, 2021 | 31,693.00 |
| Oct 31, 2018 | -57,656.00 |
| Jul 31, 2018 | -3,819.00 |